Skip to main content
. 2022 Mar 17;12(8):3354–3366. doi: 10.1016/j.apsb.2022.03.010

Figure 7.

Figure 7

(A–I) Tumor volume of each mouse in the groups treated with (A) PBS, (B) BBR, (C) Ce6+L, (D) PEG-His@BPC, (E) PEG-Phe@BRC + L, (F) PEG-His@BRC + L, (G) PEG-His@APC + L, (H) PEG-Phe@BPC + L, (I) PEG-His@BPC + L. (J) Tumor volume, (K) body weights and (L) tumor weights of different treatment groups. The a‒i represent PBS, BBR, Ce6+L, PEG-His@BPC, PEG-Phe@BRC + L, PEG-His@BRC + L, PEG-His@APC + L, PEG-Phe@BPC + L and PEG-His@BPC + L, respectively. Data are presented as mean ± SD (n = 6).